On November 22, 2024, the Zoonoses research group at OUCRU, in collaboration with Children's Hospital 2, Ho Chi Minh City, successfully organised a scientific workshop: \"Community-acquired pneumonia: Update on pneumococcal infection with vaccines, drug resistance and multiple infections\". The workshop attracted nearly 70 experts, including doctors, nurses, medical students, and technicians.
Xin Hui Chan has won the competitive 2024 Barnet Christie Lecture award of the British Infection Association. As part of the award, Dr Chan delivered a lecture entitled \u2018Drugs for Tropical Infections: Challenges, Opportunities, and the Infectious Disease Physician\u2019
An international team led by researchers from the Oxford Martin Programme on Pandemic Genomics studied how local travel patterns and mobile data from Chile can improve global pandemic responses, highlighting the importance of land-based mobility and targeted strategies.
The Kenya Medical Research Institute (KEMRI) has signed a seven-year Memorandum of Agreement with Wellcome Trust, a UK charitable organization, and the University of Oxford, on Wednesday 27 November 2024, at the KEMRI Headquarters, Nairobi. Under this collaboration, Wellcome has awarded GBP 91 million (KES 15 billion) to support research over the next 7 years.
The National Institute for Health and Care Research (NIHR) has awarded the Modernising Medical Microbiology consortium \u00a311 million to address major public health threat, antimicrobial resistance. The Oxford Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance, hosted by the Nuffield Department of Medicine since 2014, is one of 13 HPRUs funded by NIHR as part of an \u00a380 million funding boost.
A study by researchers from Oxford Population Health and Peking University, has shown that proteins carried in the blood could improve our ability to predict a person\u2019s risk of heart attack beyond conventional risk factors such as high blood pressure and genetic predisposition. The study is published in European Journal of Epidemiology.
A new study has found methaemoglobin levels during treatment for vivax malaria could be used to predict whether a patient would have recurrent malaria.
OUCRU researchers from Indonesia, Nepal, and Vietnam contributed to the newly published WHO research priorities for AMR. These top 40 priorities, developed by the World Health Organization (WHO) with global collaborators, aim to guide research into drug-resistant infections over the next five years, with a special focus on challenges faced by low- and middle-income countries (LMICs).
The Pandemic Sciences Institute has signed a Memorandum of Understanding with Universiti Malaysia Sabah (UMS), to advance a shared understanding of the risks of emerging viruses in regions rich in biodiversity.
OUCRU and the Phu Tho Department of Health have partnered to improve antibiotic stewardship and microbiology capabilities in underserved districts of the province. A recent semi-final meeting was held to review the project's progress and celebrate its achievements.
Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian Biotech Innovator, Univercells.
A new study by researchers at the Big Data Institute has shown that having current water contact is not necessarily indicative of a current schistosome infection. The study highlights the complex human-environmental drivers of transmission, showing that drivers of water contact and infection were largely distinct. The study is published in Nature Communications.
An international team of researchers, including researchers from the Oxford Martin Programme on Pandemic Genomics, have traced the global movement and evolution of seasonal influenza viruses to evaluate how the virus is impacted during pandemics.
Vietnam remains a country with a high tuberculosis burden, with tuberculous meningitis (TBM) being particularly challenging to detect early, often leading to severe neurological sequelae in patients.
New analysis by researchers at Oxford Population Health, Imperial College London, and the UK Health Security Agency (UKHSA) has found that respiratory syncytial virus (RSV) infections lead to 640,000 antibiotic prescriptions a year. The study highlights that interventions to reduce RSV infections, including the new UK vaccination programme, could help reduce antibiotic prescribing and therefore antibiotic resistance.
1.3 million women recruited over five years. Two decades of follow-up. Hundreds of research findings. It all adds up to the largest study of its kind in the world, and it\u2019s all thanks to the team at the NDPH for making it happen \u2013 as well as all the women who have taken part over the years.
Experts from across Europe joined forces to discuss research on substandard and falsified medical products and how to translate the evidence into policy and implementation. Over forty participants from various countries around the world, all based in Europe, including the UK, Sweden, France, Germany and Belgium, joined the in-person informal event at the Richard Doll Building, in Oxford, on the 24th of October.
![\"Group](\"https://034.medsci.ox.ac.uk/news/oucru-workshop-bridges-research-and-clinical-practice-on-pneumococcal-infections/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n